BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11124402)

  • 1. Effects of the serotonin 5-HT(2) antagonist, ritanserin, and the serotonin 5-HT(1A) antagonist, WAY 100635, on cocaine-seeking in rats.
    Schenk S
    Pharmacol Biochem Behav; 2000 Oct; 67(2):363-9. PubMed ID: 11124402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 5-HT1A agonist and a 5-HT2c antagonist reduce social interaction deficit induced by multiple ethanol withdrawals in rats.
    Overstreet DH; Knapp DJ; Moy SS; Breese GR
    Psychopharmacology (Berl); 2003 Jun; 167(4):344-52. PubMed ID: 12677355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 5-HT(1A) antagonist WAY 100635 can block the low-dose locomotor stimulant effects of cocaine.
    Carey R; Damianopoulos E; DePalma G
    Brain Res; 2000 Apr; 862(1-2):242-6. PubMed ID: 10799692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding.
    Fletcher PJ; Grottick AJ; Higgins GA
    Neuropsychopharmacology; 2002 Oct; 27(4):576-86. PubMed ID: 12377394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocaine increases serotonergic activity in the hippocampus and nucleus accumbens in vivo: 5-HT1a-receptor antagonism blocks behavioral but potentiates serotonergic activation.
    Müller CP; Carey RJ; De Souza Silva MA; Jocham G; Huston JP
    Synapse; 2002 Aug; 45(2):67-77. PubMed ID: 12112399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential roles of 5-HT receptor subtypes in cue and cocaine reinstatement of cocaine-seeking behavior in rats.
    Burmeister JJ; Lungren EM; Kirschner KF; Neisewander JL
    Neuropsychopharmacology; 2004 Apr; 29(4):660-8. PubMed ID: 14627998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of serotonin (5-HT)(1B) receptor ligands on cocaine-seeking behavior in rats.
    Przegaliński E; Gołda A; Filip M
    Pharmacol Rep; 2008; 60(6):798-810. PubMed ID: 19211971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychotoxicity of abused drugs: effects of serotonin receptor ligands on methamphetamine- and cocaine-induced behavioral sensitization in mice.
    Ago Y; Nakamura S; Baba A; Matsuda T
    J Pharmacol Sci; 2008 Jan; 106(1):15-21. PubMed ID: 18198473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT1A agonist/antagonist modification of cocaine stimulant effects: implications for cocaine mechanisms.
    Carey RJ; De Palma G; Damianopoulos E
    Behav Brain Res; 2002 Apr; 132(1):37-46. PubMed ID: 11853856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of serotonin (5-HT)6 receptor ligands on responding for cocaine reward and seeking in rats.
    Fijał K; Pachuta A; McCreary AC; Wydra K; Nowak E; Papp M; Bieńkowski P; Kotlińska J; Filip M
    Pharmacol Rep; 2010; 62(6):1005-14. PubMed ID: 21273657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The selective serotonin(1A)-receptor antagonist WAY 100635 blocks behavioral stimulating effects of cocaine but not ventral striatal dopamine increase.
    Müller CP; De Souza Silva MA; DePalma G; Tomaz C; Carey RJ; Huston JP
    Behav Brain Res; 2002 Aug; 134(1-2):337-46. PubMed ID: 12191821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin antagonists fail to alter MDMA self-administration in rats.
    Schenk S; Foote J; Aronsen D; Bukholt N; Highgate Q; Van de Wetering R; Webster J
    Pharmacol Biochem Behav; 2016 Sep; 148():38-45. PubMed ID: 27264435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cocaine and serotonin: a role for the 5-HT(1A) receptor site in the mediation of cocaine stimulant effects.
    Carey RJ; DePalma G; Damianopoulos E
    Behav Brain Res; 2001 Nov; 126(1-2):127-33. PubMed ID: 11704258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of serotonin (5-HT)1B receptor ligands on cocaine sensitization in rats.
    Przegalinski E; Filip M; Papla I; Siwanowicz J
    Behav Pharmacol; 2001 Apr; 12(2):109-16. PubMed ID: 11396515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that the 5-HT1A autoreceptor is an important pharmacological target for the modulation of cocaine behavioral stimulant effects.
    Carey RJ; DePalma G; Damianopoulos E; Shanahan A; Müller CP; Huston JP
    Brain Res; 2005 Feb; 1034(1-2):162-71. PubMed ID: 15713268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of WAY 100635 on antipsychotic-induced catalepsy in 5-HT depleted animals: a role for tonic activation of 5-HT(1A) receptors.
    Prinssen EP; Koek W; Kleven MS
    Eur J Pharmacol; 2000 Apr; 395(2):143-7. PubMed ID: 10794820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors.
    McCreary AC; Bankson MG; Cunningham KA
    J Pharmacol Exp Ther; 1999 Sep; 290(3):965-73. PubMed ID: 10454466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous 5-HT tonically inhibits spontaneous firing activity of dorsal hippocampus CA1 pyramidal neurons through stimulation of 5-HT(1A) receptors in quiet awake rats: in vivo electrophysiological evidence.
    Kasamo K; Suzuki T; Tada K; Ueda N; Matsuda E; Ishikawa K; Kojima T
    Neuropsychopharmacology; 2001 Feb; 24(2):141-51. PubMed ID: 11120396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatodendritic 5-HT(1A) autoreceptors mediate the anti-aggressive actions of 5-HT(1A) receptor agonists in rats: an ethopharmacological study with S-15535, alnespirone, and WAY-100635.
    de Boer SF; Lesourd M; Mocaër E; Koolhaas JM
    Neuropsychopharmacology; 2000 Jul; 23(1):20-33. PubMed ID: 10869883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.